PWP
ABBV icon

Principle Wealth Partners’s AbbVie ABBV Stock Holding History

Principle Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.17M Sell
32,482
-577
-2% -$124K 0.4% 56
2026
Q1 		$7.19M Buy
33,059
+103
+0.3% +$22.8K 0.41% 53
2025
Q4 		$7.53M Buy
32,956
+21
+0.1% +$4.78K 0.42% 50
2025
Q3 		$7.63M Buy
32,935
+132
+0.4% +$26.9K 0.44% 46
2025
Q2 		$6.09M Sell
32,803
-333
-1% -$61.9K 0.38% 53
2025
Q1 		$6.94M Sell
33,136
-615
-2% -$120K 0.5% 46
2024
Q4 		$6M Buy
33,751
+105
+0.3% +$19.3K 0.42% 52
2024
Q3 		$6.64M Sell
33,646
-100
-0.3% -$18.7K 0.47% 48
2024
Q2 		$5.79M Sell
33,746
-647
-2% -$107K 0.44% 55
2024
Q1 		$6.26M Buy
34,393
+638
+2% +$110K 0.49% 51
2023
Q4 		$5.23M Buy
33,755
+488
+1% +$71.1K 0.45% 53
2023
Q3 		$4.96M Buy
33,267
+1,340
+4% +$197K 0.5% 51
2023
Q2 		$4.3M Sell
31,927
-325
-1% -$47.7K 0.43% 57
2023
Q1 		$5.14M Sell
32,252
-2,239
-6% -$342K 0.55% 49
2022
Q4 		$5.57M Sell
34,491
-2,057
-6% -$315K 0.63% 43
2022
Q3 		$4.91K Sell
36,548
-195
-0.5% -$28K 0.46% 40
2022
Q2 		$5.63M Sell
36,743
-1,146
-3% -$175K 0.68% 35
2022
Q1 		$6.14M Sell
37,889
-268
-0.7% -$38.9K 0.65% 34
2021
Q4 		$5.17M Buy
38,157
+249
+0.7% +$29.4K 0.54% 42
2021
Q3 		$4.09M Buy
37,908
+162
+0.4% +$18.5K 0.47% 49
2021
Q2 		$4.25M Buy
37,746
+323
+0.9% +$36.4K 0.48% 46
2021
Q1 		$4.05M Buy
37,423
+2,618
+8% +$280K 0.47% 48
2020
Q4 		$3.73M Buy
+34,805
New +$3.34M 0.49% 42
2020
Q3 		– Sell
-3,069
Closed -$301K – 154
2020
Q2 		$301K Buy
+3,069
New +$270K 0.09% 117
2019
Q4 		– Sell
-3,222
Closed -$244K – 167
2019
Q3 		$244K Buy
3,222
+115
+4% +$7.88K 0.08% 141
2019
Q2 		$226K Buy
+3,107
New +$244K 0.12% 125

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Principle Wealth Partners's ABBV Position: Q2 2026 in Review

Principle Wealth Partners reduced its AbbVie (ABBV) stake by 1.7% in Q2 2026, selling an estimated $124K and leaving 32,482 shares worth $8.17M. The position accounts for 0.4% of the portfolio, ranked #56.

Principle Wealth Partners first reported a position in ABBV in Q2 2019 and has held it in 26 quarters since. 3,018 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Principle Wealth Partners held 32,482 shares of AbbVie worth $8.17M as of Q2 2026.
  • Principle Wealth Partners sold 577 AbbVie shares in Q2 2026, an estimated $124K.
  • AbbVie made up 0.4% of Principle Wealth Partners's portfolio in Q2 2026, its #56 holding.
  • Principle Wealth Partners first reported a position in AbbVie in Q2 2019 and has held it in 26 quarters since.
  • 3,018 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Principle Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.